PHF21A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.956000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.605800E-02
Normal-vs-Stage2
3.756400E-03
Normal-vs-Stage3
1.794410E-02
Normal-vs-Stage4
1.439370E-01
Stage1-vs-Stage2
8.723200E-01
Stage1-vs-Stage3
1.169790E-01
Stage1-vs-Stage4
5.670800E-01
Stage2-vs-Stage3
1.462810E-01
Stage2-vs-Stage4
6.468400E-01
Stage3-vs-Stage4
1.700410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.642500E-03
Normal-vs-AfricanAmerican
4.969900E-02
Normal-vs-Asian
1.670160E-02
Caucasian-vs-AfricanAmerican
9.411800E-01
Caucasian-vs-Asian
3.306800E-01
AfricanAmerican-vs-Asian
5.466800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.597400E-03
Normal-vs-Female
2.362800E-03
Male-vs-Female
7.919600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.057610E-01
Normal-vs-Age(41-60Yrs)
1.313670E-02
Normal-vs-Age(61-80Yrs)
1.641700E-03
Normal-vs-Age(81-100Yrs)
5.595300E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.795600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.107800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.029800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.437400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.175700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.514800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.317070E-03
Normal-vs-Daily Drinker
6.958300E-04
Normal-vs-Weekly Drinker
1.125650E-02
Normal-vs-Occasional Drinker
4.700000E-02
Normal-vs-Social Drinker
9.960200E-02
Non Drinker-vs-Daily Drinker
8.993200E-01
Non Drinker-vs-Weekly Drinker
5.566000E-01
Non Drinker-vs-Occasional Drinker
1.778080E-02
Non Drinker-vs-Social Drinker
2.027900E-02
Daily Drinker-vs-Weekly Drinker
6.141800E-01
Daily Drinker-vs-Occasional Drinker
2.199800E-02
Daily Drinker-vs-Social Drinker
2.551600E-02
Weekly Drinker-vs-Occasional Drinker
1.486150E-01
Weekly Drinker-vs-Social Drinker
1.492200E-01
Occasional Drinker-vs-Social Drinker
8.537800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.668300E-02
Normal-vs-Grade 2
1.189530E-02
Normal-vs-Grade 3
1.418220E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.003200E-01
Grade 1-vs-Grade 3
2.520800E-01
Grade 1-vs-Grade 4
9.668300E-02
Grade 2-vs-Grade 3
6.935000E-01
Grade 2-vs-Grade 4
1.189530E-02
Grade 3-vs-Grade 4
1.418220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.841120E-03
Normal-vs-NonDiabetic
2.024500E-03
Diabetic-vs-NonDiabetic
6.345400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.940000E-02
Normal-vs-NoPancreatitis
1.401730E-03
Pancreatitis-vs-NoPancreatitis
2.421800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.500500E-03
Normal-vs-N1
3.041800E-03
N0-vs-N1
6.928800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.128010E-02
Normal-vs-TP53-NonMutant
2.994500E-02
TP53-Mutant-vs-TP53-NonMutant
9.327600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
